percentage of Service subsequent process in Users referred to an IAPT accordance with GC9 programme who are treated within 18 weeks of referral Full implementation of an Failure to Review of Service Quality 5% of the Actual Monthly Monthly Where both effective e-Prescribing produce a Performance Reports for the Services Specialised system for chemotherapy robust provided under Service Services and across all relevant clinical implementation Specification B15/S/a Cancer apply teams within the Provider plan, by 30 June (Cancer: Chemotherapy (other than those dealing 2016, to achieve (Adult) per month, until a with children, teenagers full robust implementation and and young adults) implementation plan is produced across all tumour sites as described under Service Specification B15/S/a Cancer: Chemotherapy (Adult) by 31 March 2017 Full implementation of an Failure to Review of Service Quality 5% of the Actual Monthly Monthly Where both effective e-Prescribing produce a Performance Reports Value for the Services Specialised system for chemotherapy robust provided under Service Services and across all relevant clinical implementation Specification B15/S/b Cancer apply teams within the Provider plan, by 30 Cancer: Chemotherapy dealing with children, September 2016 (Children, Teenagers and teenagers and young to achieve full Young Adults) per month, adults across all tumour implementation until a sites as described robust implementation under Service plan is produced Specification B15/S/b Cancer:
percentage of Service Users referred to an IAPT programme who are treated within 18 weeks of referral subsequent process in accordance with GC9 Full implementation of an effective e-Prescribing system for chemotherapy across all relevant clinical teams within the Provider (other than those dealing with children, teenagers and and young adults) across all tumour sites Failure to produce a robust implementation plan, by 30 June 2016, to achieve full implementation as described under Service Specification B15/S/a Cancer: Chemotherapy (Adult) by 31 March 2017 Review of Service Quality Performance Reports 5% of the Actual Monthly for the Services provided under Service Specification B15/S/a (Cancer: Chemotherapy (Adult) per month, until a robust implementation plan is produced Monthly Where both Specialised Services and Cancer apply Full implementation of an effective e-Prescribing system for chemotherapy across all relevant clinical teams within the Provider dealing with children, teenagers and young adults across all tumour sites Failure to produce a robust implementation plan, by 30 September 2016 to achieve full implementation as described under Service Specification B15/S/b Cancer: Review of Service Quality Performance Reports 5% of the Actual Monthly Value for the Services provided under Service Specification B15/S/b Cancer: Chemotherapy (Children, Teenagers and Young Adults) per month, until a robust implementation plan is produced Monthly Where both Specialised Services and Cancer apply